Hermann W. D. Katinger
#154,732
Most Influential Person Now
Hermann W. D. Katinger's AcademicInfluence.com Rankings
Hermann W. D. Katingerbiology Degrees
Biology
#11851
World Rank
#15279
Historical Rank
Virology
#285
World Rank
#292
Historical Rank
Immunology
#777
World Rank
#800
Historical Rank
Download Badge
Biology
Hermann W. D. Katinger's Degrees
- PhD Virology University of Vienna
- Doctorate Medicine University of Vienna
Why Is Hermann W. D. Katinger Influential?
(Suggest an Edit or Addition)Hermann W. D. Katinger's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies (2000) (1364)
- Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 (1996) (1138)
- A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 (1993) (1080)
- Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection (2000) (924)
- HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites (2002) (924)
- Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41 (2001) (849)
- Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies (1999) (838)
- Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies (2004) (757)
- Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition (2003) (745)
- Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies (2005) (741)
- The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120 (2002) (700)
- The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120 (2002) (570)
- A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. (2001) (548)
- Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies (2005) (541)
- Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG (1995) (513)
- Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope (2004) (492)
- Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. (2005) (469)
- Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS (1994) (312)
- Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Antibodies 2F5 and 4E10 Require Surprisingly Few Crucial Residues in the Membrane-Proximal External Region of Glycoprotein gp41 To Neutralize HIV-1 (2005) (290)
- Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. (2005) (281)
- Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. (1999) (266)
- hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. (2008) (252)
- The complete nucleotide sequence of plum pox virus RNA. (1989) (224)
- Transfectant Influenza A Viruses with Long Deletions in the NS1 Protein Grow Efficiently in Vero Cells (1998) (220)
- Efficient transformation of Agrobacterium spp. by electroporation. (1989) (215)
- Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo‐Fc expressing CHO cells cultivated in controlled batch bioreactors (2006) (214)
- Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5 (1996) (189)
- Effect of Increased Expression of Protein Disulfide Isomerase and Heavy Chain Binding Protein on Antibody Secretion in a Recombinant CHO Cell Line (2008) (182)
- Neutralization Sensitivity of Human Immunodeficiency Virus Type 1 Primary Isolates to Antibodies and CD4-Based Reagents Is Independent of Coreceptor Usage (1998) (181)
- Neutralization Synergy of Human Immunodeficiency Virus Type 1 Primary Isolates by Cocktails of Broadly Neutralizing Antibodies (2001) (180)
- Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. (2005) (177)
- Fine Definition of the Epitope on the gp41 Glycoprotein of Human Immunodeficiency Virus Type 1 for the Neutralizing Monoclonal Antibody 2F5 (2001) (176)
- Postnatal Passive Immunization of Neonatal Macaques with a Triple Combination of Human Monoclonal Antibodies against Oral Simian-Human Immunodeficiency Virus Challenge (2001) (169)
- Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies. (2004) (161)
- The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate (1996) (151)
- Plant Protein Hydrolysates: Preparation of Defined Peptide Fractions Promoting Growth and Production in Animal Cells Cultures (2000) (150)
- Acquisition of host cell‐surface‐derived molecules by HIV‐1 (1996) (150)
- Entrapment of animal cells for production of monoclonal antibodies and other biomolecules (1983) (147)
- Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus. (1996) (142)
- The promoter of an apple Ypr10 gene, encoding the major allergen Mal d 1, is stress- and pathogen-inducible (2000) (132)
- Immunogenicity and Protection Efficacy of Replication-Deficient Influenza A Viruses with Altered NS1 Genes (2004) (132)
- A Novel Ultrasonic Resonance Field Device for the Retention of Animal Cells (1994) (132)
- A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1 (2002) (127)
- The Long Third Complementarity-Determining Region of the Heavy Chain Is Important in the Activity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 (2004) (124)
- Adjunctive Passive Immunotherapy in Human Immunodeficiency Virus Type 1-Infected Individuals Treated with Antiviral Therapy during Acute and Early Infection (2007) (121)
- Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5. (1998) (119)
- Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. (2003) (117)
- Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques (2003) (114)
- Characterization of Human Class-Switched Polymeric (Immunoglobulin M [IgM] and IgA) Anti-Human Immunodeficiency Virus Type 1 Antibodies 2F5 and 2G12 (2003) (111)
- Preparative purification of human monoclonal antibody isoforms in a multi-compartment electrolyser with immobiline membranes. (1990) (110)
- Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12. (2004) (105)
- Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation (2002) (104)
- Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice. (2005) (102)
- Comparison of early passage, senescent and hTERT immortalized endothelial cells. (2005) (97)
- Virus Isolates during Acute and Chronic Human Immunodeficiency Virus Type 1 Infection Show Distinct Patterns of Sensitivity to Entry Inhibitors (2005) (97)
- Subtractive Hybridization of mRNA from early passage and senescent endothelial cells (2000) (97)
- Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion. (2007) (96)
- In Vivo and In Vitro Escape from Neutralizing Antibodies 2G12, 2F5, and 4E10 (2007) (95)
- Baculovirus surface display: construction and screening of a eukaryotic epitope library. (1998) (95)
- Expression of foreign proteins on the surface of Autographa californica nuclear polyhedrosis virus. (1997) (94)
- Neutralizing Monoclonal Antibodies Block Human Immunodeficiency Virus Type 1 Infection of Dendritic Cells and Transmission to T Cells (1998) (93)
- Telomerase immortalized human amnion- and adipose-derived mesenchymal stem cells: maintenance of differentiation and immunomodulatory characteristics. (2009) (91)
- Process parameter shifting: Part II. Biphasic cultivation—A tool for enhancing the volumetric productivity of batch processes using Epo‐Fc expressing CHO cells (2006) (91)
- THE CROSSFLOW INJECTION TECHNIQUE: AN IMPROVEMENT OF THE ETHANOL INJECTION METHOD (2002) (91)
- Rescue of influenza virus expressing GFP from the NS1 reading frame. (2004) (90)
- The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus. (1988) (90)
- Regeneration of transgenic plants of Prunus armeniaca containing the coat protein gene of Plum Pox Virus (1992) (89)
- Antibody Neutralization-Resistant Primary Isolates of Human Immunodeficiency Virus Type 1 (1998) (86)
- Neutralization Profiles of Newly Transmitted Human Immunodeficiency Virus Type 1 by Monoclonal Antibodies 2G12, 2F5, and 4E10 (2004) (85)
- Liposomes produced in a pilot scale: production, purification and efficiency aspects. (2002) (85)
- Synergistic Neutralization of Simian-Human Immunodeficiency Virus SHIV-vpu+ by Triple and Quadruple Combinations of Human Monoclonal Antibodies and High-Titer Anti-Human Immunodeficiency Virus Type 1 Immunoglobulins (1998) (85)
- Efficient selection of high-producing subclones during gene amplification of recombinant Chinese hamster ovary cells by flow cytometry and cell sorting. (2000) (85)
- Contributions of DNA interstrand cross-links to aging of cells and organisms (2007) (83)
- GMP Production of Liposomes—A New Industrial Approach (2006) (83)
- Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity (2006) (81)
- Functional analysis of the broadly neutralizing human anti‐HIV‐1 antibody 2F5 produced in transgenic BY‐2 suspension cultures (2007) (81)
- Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody. (2004) (77)
- Long-Term Multiple-Dose Pharmacokinetics of Human Monoclonal Antibodies (MAbs) against Human Immunodeficiency Virus Type 1 Envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5) (2006) (77)
- A PCR membrane spot assay for the detection of plum pox virus RNA in bark of infected trees. (1991) (76)
- Membrane association and epitope recognition by HIV-1 neutralizing anti-gp41 2F5 and 4E10 antibodies. (2006) (75)
- Improved detection methods for fruit tree phytoplasmas (2001) (74)
- Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope (2009) (73)
- Hyperattenuated Recombinant Influenza A Virus Nonstructural-Protein-Encoding Vectors Induce Human Immunodeficiency Virus Type 1 Nef-Specific Systemic and Mucosal Immune Responses in Mice (2001) (73)
- Determination of liposome size distribution by flow cytometry. (2000) (70)
- Topically applied liposome encapsulated superoxide dismutase reduces postburn wound size and edema formation. (2001) (69)
- MicroRNAs as targets for engineering of CHO cell factories. (2008) (69)
- Changes during subclone development and ageing of human antibody-producing recombinant CHO cells. (1999) (68)
- The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12. (2003) (67)
- Selective Retention of Viable Cells in Ultrasonic Resonance Field Devices (1996) (67)
- Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern. (2003) (66)
- SNEV overexpression extends the life span of human endothelial cells. (2006) (65)
- Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins. (1997) (63)
- Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells. (2000) (63)
- Cellular Immunity Elicited by Human Immunodeficiency Virus Type 1/ Simian Immunodeficiency Virus DNA Vaccination Does Not Augment the Sterile Protection Afforded by Passive Infusion of Neutralizing Antibodies (2003) (60)
- In Vivo Efficacy of Human Immunodeficiency Virus Neutralizing Antibodies: Estimates for Protective Titers (2007) (59)
- Direct cloning into the Autographa californica nuclear polyhedrosis virus for generation of recombinant baculoviruses. (1994) (59)
- Influenza Virus NS Vectors Expressing the Mycobacterium tuberculosis ESAT-6 Protein Induce CD4+ Th1 Immune Response and Protect Animals against Tuberculosis Challenge (2006) (59)
- Chimeric influenza virus replicating predominantly in the murine upper respiratory tract induces local immune responses against human immunodeficiency virus type 1 in the genital tract. (1998) (59)
- SNEV is an evolutionarily conserved splicing factor whose oligomerization is necessary for spliceosome assembly (2005) (59)
- Specific phospholipid recognition by human immunodeficiency virus type‐1 neutralizing anti‐gp41 2F5 antibody (2006) (58)
- HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies (2005) (58)
- Interaction of U-box E3 ligase SNEV with PSMB4, the beta7 subunit of the 20 S proteasome. (2005) (58)
- Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study. (2005) (57)
- Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B. (2001) (56)
- Generation of an Influenza A Virus Vector Expressing Biologically Active Human Interleukin-2 from the NS Gene Segment (2005) (55)
- Biochemical characterization of rhEpo-Fc fusion protein expressed in CHO cells. (2006) (54)
- MdAP, a novel protein in apple, is associated with the major allergen Mal d 1. (2003) (52)
- Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine. (2004) (51)
- Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies. (2001) (51)
- Postnatal pre‐ and postexposure passive immunization strategies: protection of neonatal macaques against oral simian–human immunodeficiency virus challenge (2002) (51)
- Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data (2007) (51)
- Characterisation of recombinant CHO cell lines by investigation of protein productivities and genetic parameters. (2007) (49)
- Early Embryonic Lethality of Mice Lacking the Essential Protein SNEV (2007) (47)
- Reepithelialization of experimental scalds effected by topically applied superoxide dismutase: controlled animal studies (2002) (46)
- Localization of fruit tree viruses by immuno-tissue printing in infected shoots of Malus sp. and Prunus sp. (1995) (46)
- Enhancement of Monoclonal Antibody Production by Lysine‐Containing Peptides (2003) (46)
- Mapping of Malus domestica allergens by 2‐D electrophoresis and IgE‐reactivity (2007) (45)
- Expanding baculovirus surface display. Modification of the native coat protein gp64 of Autographa californica NPV. (2000) (45)
- Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry? (1997) (44)
- Somatic embryogenesis of Prunus subhirtella autumno rosa and regeneration of transgenic plants after Agrobacterium-mediated transformation (1995) (44)
- High level expression of a promising anti-idiotypic antibody fragment vaccine against HIV-1 in Pichia pastoris. (2007) (43)
- Specific Effects of Synthetic Oligopeptides on Cultured Animal Cells (2002) (42)
- Screening for improved cell performance: selection of subclones with altered production kinetics or improved stability by cell sorting. (2004) (41)
- Comparison of protein A, protein G and copolymerized hydroxyapatite for the purification of human monoclonal antibodies. (1989) (40)
- Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques. (2007) (39)
- Nebulization of Liposomal rh-Cu/Zn–SOD with a Novel Vibrating Membrane Nebulizer (2006) (39)
- Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. (2006) (38)
- Analysis of changes during subclone development and ageing of human antibody-producing heterohybridoma cells by northern blot and flow cytometry. (1999) (38)
- Transgenic grapevines expressing coat protein gene sequences of grapevine fanleaf virus, arabis mosaic virus, grapevine virus a and grapevine virus B (2000) (37)
- The HIV-Neutralizing Monoclonal Antibody 4E10 Recognizes N-Terminal Sequences on the Native Antigen1 (2006) (37)
- Modular Integrated Fluidized Bed Bioreactor Technology (1991) (37)
- Characterization of a trimeric MPER containing HIV-1 gp41 antigen. (2009) (37)
- Altering the surface properties of baculovirus Autographa californica NPV by insertional mutagenesis of the envelope protein gp64. (2002) (36)
- Conformational changes of Mal d 2, a thaumatin-like apple allergen, induced by food processing. (2009) (36)
- Scale-up engineering in animal cell technology: Part II (1988) (36)
- New aspects of virus elimination in fruit trees. (1995) (36)
- Passive immunization against oral AIDS virus transmission: An approach to prevent mother‐to‐infant HIV‐1 transmission? (2001) (36)
- A peptide inhibitor of HIV‐1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120 (2008) (35)
- Protein‐free transfection of CHO host cells with an IgG‐fusion protein: Selection and characterization of stable high producers and comparison to conventionally transfected clones (2007) (35)
- Aging and the ubiquitinome: Traditional and non-traditional functions of ubiquitin in aging cells and tissues (2006) (34)
- Live cold-adapted influenza A vaccine produced in Vero cell line. (2004) (34)
- Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning. (2006) (34)
- A simple and robust method for the complete dissociation of HIV-1 p24 and other antigens from immune complexes in serum and plasma samples. (1998) (33)
- Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection. (2003) (33)
- Live Attenuated Influenza Virus Expressing Human Interleukin-2 Reveals Increased Immunogenic Potential in Young and Aged Hosts (2006) (33)
- Primary African HIV clade A and D isolates: effective cross-clade neutralization with a quadruple combination of human monoclonal antibodies raised against clade B. (2003) (32)
- Mapping of fruit allergens by 2D electrophoresis and immunodetection (2008) (32)
- Anti-idiotypic antibody Ab2/3H6 mimics the epitope of the neutralizing anti-HIV-1 monoclonal antibody 2F5. (2002) (32)
- ENHANCED PROTEIN LOADING INTO LIPOSOMES BY THE MULTIPLE CROSSFLOW INJECTION TECHNIQUE (2002) (32)
- Coat protein mediated resistance to Plum Pox Virus in Nicotiana clevelandii and N. benthamiana (1992) (32)
- Evaluation of a genomics platform for cross‐species transcriptome analysis of recombinant CHO cells (2006) (31)
- Identification of four IgE-reactive proteins in raspberry (Rubus ideaeus L.). (2008) (30)
- An in vitro test system for thyroid hormone action. (1996) (29)
- The absence of effect of gene copy number and mRNA level on the amount of mAb secretion from mammalian cells (2008) (29)
- Fruit cross-reactive allergens: a theme of uprising interest for consumers' health. (2005) (29)
- HIV-1 gp41 binds to several proteins on the human B-cell line, Raji. (1993) (27)
- Identification of transgene integration loci of different highly expressing recombinant CHO cell lines by FISH (2006) (26)
- Potent Human Immunodeficiency Virus-Neutralizing and Complement Lysis Activities of Antibodies Are Not Obligatorily Linked (2008) (26)
- Production kinetics of monoclonal antibodies. (1985) (25)
- Bacterial expression and refolding of human trypsinogen. (2004) (25)
- Pilot scale production of a human monoclonal antibody against human immunodeficiency virus HIV-1. (1989) (25)
- Growth and production kinetics of human x mouse and mouse hybridoma cells at reduced temperature and serum content. (1992) (25)
- Effects of Antibody on Viral Kinetics in Simian/Human Immunodeficiency Virus Infection: Implications for Vaccination (2004) (24)
- Rational design of an improved induction scheme for recombinant Escherichia coli. (1998) (24)
- Long-term stability of marker gene expression in Prunus subhirtella: a model fruit tree species. (2007) (24)
- HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II expression by gp41. (1994) (23)
- Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity. (2006) (23)
- Phytoplasma infected plants in Austrian forests: role as a reservoir? (2007) (23)
- Flow cytometric analysis of bacterial physiology during induction of foreign protein synthesis in recombinant Escherichia coli cells. (1998) (23)
- Construction of a large scale membrane reactor system with different compartments for cells, medium and product. (1987) (23)
- CEPO-Fc (An EPO Derivative) Protects Hippocampus Against Aβ-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of Aβ Toxicity (2018) (23)
- Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6. (2008) (22)
- Industrial animal cell reactor systems: aspects of selection and evaluation. (1991) (22)
- Transcriptional profiling of phenotypically different Epo‐Fc expressing CHO clones by cross‐species microarray analysis (2008) (22)
- Coat protein-mediated protection against plum pox virus in herbaceous model plants and transformation of apricot and plum (1992) (21)
- Long term stability of rh-Cu/Zn-superoxide dismutase (SOD)-liposomes prepared by the cross-flow injection technique following International Conference on Harmonisation (ICH)-guidelines. (2002) (21)
- Entrapment of animal cells for the production of biomolecules such as monoclonal antibodies. (1983) (21)
- Transformation of somatic embryos of Vitis sp. (grapevine) with different constructs containing nucleotide sequences from nepovirus coat protein genes (1997) (21)
- Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain. (1992) (21)
- Experimental design for in vitro skin penetration study of liposomal superoxide dismutase. (2006) (21)
- Optimization of recombinant protein expression level in Escherichia coli by flow cytometry and cell sorting. (2002) (21)
- A simple method to quantify staphylococcal protein A in the presence of human or animal IgG in various samples. (2000) (21)
- Increased biological half-life of aerosolized liposomal recombinant human Cu/Zn superoxide dismutase in pigs. (2008) (20)
- Status and developments of animal cell technology using suspension culture techniques (1982) (20)
- Confocal microscopy of giant vesicles supports the absence of HIV‐1 neutralizing 2F5 antibody reactivity to plasma membrane phospholipids (2010) (20)
- The human monocyte cell line U937 binds HIV-1 gp41 by proteins of 37, 45, 49, 62 and 92 kDa. (1993) (20)
- The use of macroporous gelatin carriers for the cultivation of mammalian cells in fluidised bed reactors (1990) (20)
- Flow cytometric analysis of metabolic stress effects due to recombinant plasmids and proteins in Escherichia coli production strains. (1999) (20)
- High-performance liquid chromatographic determination of metabolic products for fermentation control of mammalian cell culture: analysis of carbohydrates, organic acids and orthophosphate using refractive index and ultraviolet detectors. (1989) (20)
- A host restriction-based selection system for influenza haemagglutinin transfectant viruses. (1998) (19)
- Shifts of isoelectric points between cellular and secreted antibodies as revealed by isoelectric focusing and immobilized pH gradients (1990) (19)
- Nuclear Flow FISH: Isolation of cell nuclei improves the determination of telomere lengths (2006) (19)
- Isolation of human monoclonal antibody isoproteins by preparative isoelectric focusing in immobilized pH gradients. (1989) (19)
- Serum-free transfection of CHO cells with chemically defined transfection systems and investigation of their potential for transient and stable transfection (2009) (19)
- Establishment of human fibroma cell lines from a MEN1 patient by introduction of either hTERT or SV40 early region. (2005) (19)
- A new, efficient method using 8-hydroxy-quinolinol-sulfate for the initiation and establishment of tissue cultures of apple from adult material (1991) (19)
- Biotechnology of temperate fruit trees and grapevines. (2005) (18)
- On-Line Detection of Microbial Contaminations in Animal Cell Reactor Cultures Using an Electronic Nose Device (2005) (18)
- Improvement of the energy metabolism of recombinant CHO cells by cell sorting for reduced mitochondrial membrane potential. (2007) (18)
- Electron microscopic and immunochemical analysis of the broadly neutralizing HIV-1-specific, anti-carbohydrate antibody, 2G12. (2004) (18)
- HIV-1 gp41 binding to human peripheral blood mononuclear cells occurs preferentially to B Lymphocytes and monocytes. (1993) (18)
- REGENERATION OF SHOOTS FROM LEAF DISCS AND STEM MICROCUTTINGS OF FRUIT TREES AS A TOOL FOR TRANSFORMATION (1989) (18)
- One Step Membrane Incorporation of Viral Antigens as a Vaccine Candidate Against HIV (2007) (17)
- Capillary zone electrophoresis for monitoring r-DNA protein purification in multi-compartment electrolysers with immobiline membranes. (1990) (17)
- Dhanier Ft Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp 41 (2009) (17)
- Isoelectric precipitation and gel chromatography for purification of monoclonal IgM (1987) (17)
- Age-related alterations in the protein expression profile of C57BL/6J mouse pituitaries (2002) (16)
- Engineered gene for Escherichia coli alkaline phosphatase for the construction of translational fusions. (1990) (16)
- Rhodamine 123 fluorescence of immortal hybridoma cell lines as a function of glucose concentration. (1993) (16)
- Nucleotide sequence of AMV-capsid protein-gene. (1990) (15)
- Influence of transfected SV40 early region on growth and differentiation of human endothelial cells. (1992) (15)
- IgM characterization directly performed in crude culture supernatants by a new simple electrophoretic method. (2010) (15)
- Proline Is Not Uniquely Capable of Providing the Pivot Point for Domain Swapping in 2G12, a Broadly Neutralizing Antibody against HIV-1* (2009) (14)
- Validated method for quantification of genetically modified organisms in samples of maize flour. (2006) (14)
- [35] Entrapment of animal cells (1987) (14)
- Structural analysis and in vivo administration of an anti-idiotypic antibody against mAb 2F5. (2008) (14)
- Low telomerase activity: possible role in the progression of human medullary thyroid carcinoma. (2008) (13)
- Improvement of the energy metabolism of recombinant CHO cells by cell sorting for reduced mitochondrial membrane potential (2006) (13)
- Blom7α Is a Novel Heterogeneous Nuclear Ribonucleoprotein K Homology Domain Protein Involved in Pre-mRNA Splicing That Interacts with SNEVPrp19-Pso4* (2009) (13)
- Partial humanization and characterization of an anti-idiotypic antibody against monoclonal antibody 2F5, a potential HIV vaccine? (2007) (13)
- Principles of animal cell fermentation. (1987) (13)
- HIV-1 gp41 enhances major histocompatibility complex class I and ICAM-1 expression on H9 and U937 cells. (1994) (12)
- Cross-Neutralizing Human Monoclonal Anti-HIV-1 Antibody 2F5: Preparation and Crystallographic Analysis of the Free and Epitope-Complexed Forms of its F ab Fragment (2001) (12)
- Combination of Zetaprep mass ion-exchange media and high-performance cation-exchange chromatography for the purification of high-purity monoclonal antibodies. (1987) (12)
- Direct evidence for the presence of allergens in Rosaceae fruit tree pollen (2006) (12)
- Expression of a Fab Fragment in CHO and Pichia pastoris A Comparative Case Study (2008) (11)
- Production of monoclonal antibodies by agarose-entrapped hybridoma cells. (1986) (10)
- Effect of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) on learning and memory impairment and hippocampal apoptosis induced by intracerebroventricular administration of streptozotocin in rats (2020) (10)
- DEVELOPMENT OF A NEW TYPE OF MACROPOROUS CARRIER (1992) (10)
- Screening and identification of putative allergens in berry fruits of the Rosaceae family: Technical challenges (2008) (10)
- EXPRESSION OF THE COAT PROTEIN GENES OF GRAPEVINE VIRUS A AND B IN NICOTIANA SPECIES AND EVALUATION OF THE RESISTANCE CONFERRED ON TRANSGENIC PLANTS (1998) (10)
- Analysis of alterations in gene expression after amplification of recombinant genes in CHO cells. (2001) (10)
- Improved virus detection in rosaceous fruit trees in vitro (2004) (10)
- A laboratory fermentor for agarose immobilized hybridomas to produce monoclonal antibodies. (1985) (9)
- DISTRIBUTION OF APPLE CHLOROTIC LEAFSPOT VIRUS IN APPLE SHOOTS CULTIVATED IN VITRO (1995) (9)
- Simultaneous Quantification of Complex Phospholipid Compositions Containing Monophosphoryl Lipid-A by RP-HPLC (2009) (9)
- CEPO (carbamylated erythropoietin)-Fc protects hippocampal cells in culture against beta amyloid-induced apoptosis: considering Akt/GSK-3β and ERK signaling pathways (2020) (9)
- Human endothelial cell lines established by mutated forms of the simian virus 40 large T oncogene. (1997) (9)
- Gene transfer methods for the pathogen-mediated resistance breeding in fruit trees (1995) (9)
- Early screening for anti-plum pox virus monoclonal antibodies with different epitope specificities by means of gold-labelled immunosorbent electron microscopy. (1988) (9)
- Amino-acid sequence comparison of nepovirus coat proteins (1992) (9)
- A modular computer-controlled fermentation pilot-plant (1991) (9)
- Physiological response ofCandida tropicalis grown on n-paraffin to mixing in a tubular closed loop fermenter (1976) (9)
- Genetic Diversity and Population Structure of Apricot (Prunus armeniaca L.) from Northern Pakistan using Simple Sequence Repeats (2008) (8)
- IDENTIFICATION OF THE COAT PROTEIN GENE OF ARABIS MOSAIC NEPOVIRUS AND ITS EXPRESSION IN TRANSGENIC PLANTS (1992) (8)
- Human monoclonal antibodies for passive immunotherapy of HIV-1. (1994) (8)
- Expression of SV40 tumour antigens enables human endothelial cells to grow independently from foetal calf serum and exogenous growth factors. (1994) (8)
- Expression of a Human Monoclonal Anti‐HIV‐1 Antibody in CHO Cells a (1991) (8)
- Serum-free transfection of CHO-cells with tailor-made unilamellar vesicles (2007) (8)
- PHYTOSANITARY IMPROVEMENT OF FRUIT TREE SPECIES: DIAGNOSTIC STRATEGIES IN VIRUS-INDEXING OF IN VITRO PLANTS (1998) (7)
- Detection of the trans activity of the plum pox virus NIa-like protease in infected plants. (1990) (7)
- Development of standardized cell culture conditions for tumor cells with potential clinical application. (2007) (7)
- Establishment of a strategy for the rapid generation of a monoclonal antibody against the human protein SNEV (hNMP200) by flow-cytometric cell sorting. (2005) (7)
- A novel strategy for quantitative isoform detection directly performed from culture supernatant. (2006) (7)
- Entrapment of animal cells. (1987) (7)
- Cytokine activity assay by means of proliferation measured in plane convex microtiter wells. (1996) (6)
- Stable, continuous large-scale production of human monoclonal HIV-1 antibody using a computer-controlled pilot plant. (1994) (6)
- Two-dimensional gel electrophoresis for controlling and comparing culture supernatants of mammalian cell culture productions systems (2004) (6)
- Electroporative gene transfer (electrotransfection): A method for strain improvement of animal cells (1987) (6)
- Large-Scale Production and Characterization of Novel CD4+ Cytotoxic T Cells with Broad Tumor Specificity for Immunotherapy (2009) (6)
- Transformation and regeneration of plants of Prunus armeniaca with the coat protein gene of plum pox virus. (1992) (5)
- Self-hybridization of hybridomas leads to stabilization of clones and increased yield of monoclonal antibodies. (1987) (5)
- Expression of the plum pox virus coat protein gene in Nicotiana clevelandii. (1990) (5)
- SCALE-UP OF A FLUIDIZED BED REACTOR OPERATED WITH POROUS GLASS CARRIERS (1992) (5)
- Specific Effects of Synthetic Oligopeptides in Animal Cell Culture (2001) (5)
- Expression, Purification, and In Vivo Administration of a Promising Anti-Idiotypic HIV-1 Vaccine (2008) (5)
- Process Development for the Large Scale Production of Clinical Grade Human Monoclonal Antibody Using a Cytopilot Fluidized Bed Reactor (1997) (5)
- , Epitope 1 Antibody 2 F 5 in Complex with Its gp 41 Anti-Human Immunodeficiency Virus Type Structure and Mechanistic Analysis of the (2004) (5)
- Monoclonal Antibody Production Using the Porous Glass Bead Immobilization Technique (1992) (5)
- Stability of von Willebrand Factor secretion in different human endothelial hybrid cell lines (2006) (5)
- Comparison of the production of a human monoclonal antibody against HIV-1 by heterohybridoma cells and recombinant CHO cells: A flow cytometric study (2004) (5)
- The envelope of HIV. (1996) (5)
- HIV-1 gp41 shares a common immunologic determinant with normal human blood lymphocytes and monocytes. (1994) (5)
- Novel human renal proximal tubular cell line for the production of complex proteins. (2014) (5)
- Enhancement of HIV-1 gp41 binding to raji cells by pwm, lps, interferon-γ and interleukin-6 (1993) (5)
- PROGRESS IN PATHOGEN-MEDIATED RESISTANCE BREEDING AGAINST PLUM POX VIRUS (1995) (4)
- Characteristics of Large-Scale Production of Phyto-Sanitary Improved In-Vitro Fruit Tree Cultivars Using In-Vitro Elimination Treatments and Serodiagnostics (1997) (4)
- Unsung Hero Robert C. Gallo (2009) (4)
- Influence of interfacial area and nonutilizable hydrocarbons on growth kinetics of Candida sp. in hydrocarbon fermentations. (1973) (4)
- Stabilizing effect of reduced cultivation temperature on human x mouse hybridomas. (1985) (4)
- Applicability of different fluorescent dyes for isoform quantification on linear IPG gels (2007) (4)
- HIV-1 gp41 shares a common immunologic determinant with human T, B and monocyte cell lines. (1994) (4)
- PROTEIN FREE CULTURE OF R-CHO AND HYBRIDOMA CELLS ON THE MACROPOROUS POLYPORE® CARRIER (1994) (4)
- OXYGENATION IN FLUIDIZED BED BIOREACTORS USING THE MICROSPARGING TECHNIQUE (1992) (3)
- High density microcarrier culture with a new device which allows oxygenation and perfusion of microcarrier cultures (2004) (3)
- Automated glucose measurement with microstructured thin-layer bionsensors for the control of fermentation processes (1994) (3)
- Scale-Up of Ultrasonic Resonance Field Cell Separation Devices Used in Animal Cell Technology (1995) (3)
- PILOT-SCALE MODULAR HARD-AND SOFTWARE CONCEPT FOR ANIMAL CELL FERMENTATION (1992) (3)
- Purification of HBsAg produced by the human hepatoma cell line PLC/PRE/5 by affinity chromatography using monoclonal antibodies and application for ELISA diagnostic. (1983) (3)
- Hormonal Optimization and Morphological Characterization of the 'M9 Jork' Stem and Disc System. Towards its Biochemical Characterization (1994) (3)
- Fluidized Bed Technology: Influence of Fluidization Velocity on Nutrient Consumption and Product Expression (1998) (3)
- Control of Key Parameters in Developing Mammalian Production Clones (2004) (3)
- PRODUCTION OF THE HIV-1 NEUTRALISING HUMAN MONOCLONAL ANTIBODY 2F5: STIRRED TANK VERSUS FLUIDIZED BED CULTURE (1994) (3)
- Rhizogenesis in stem discs of Malus pumila rootstock M9 “Jork”: I. Hormonal and environmental effects on root induction and callus formation (1995) (3)
- ALTERNATIVE STRATEGIES TO FIGHT APPLE SCAB (2002) (2)
- Approaches to pathogen‐mediated resistance breeding against plum pox potyvirus in stone‐fruit trees1 (1994) (2)
- Production of Recombinant Human Trypsinogen in Escherichia Coli and Pichia Pastoris (2001) (2)
- Continuous Perfused Fluidized Bed Technology (1999) (2)
- Scale-Up Optimization Based on the Development of a Perfusion Rate Control for CHO Cells Using a Cytopilot Fluidized Bed Reactor (1997) (2)
- Enhancement of HIV-1 gp41 binding to Raji cells by PWM, LPS, interferon-gamma and interleukin-6. (1993) (2)
- Flow cytometry and two-dimensional electrophoresis (2-DE) for system evaluation of long term continuous perfused animal cell cultures in macroporous beads (2006) (2)
- INTERFERON-α PRIMES EARLY PROLIFERATIVE RESPONSE OF BONE MARROW CELLS IN VIVO (1998) (2)
- HIGH DENSITY AGGREGATE CULTURE OF RECOMBINANT CHO CELLS IN FLUIDIZED BED BIOREACTORS (1992) (2)
- Expression of the plum pox virus coat protein region in Escherichia coli (1989) (1)
- Experience with testing for mycoplasma with five different methods. (1979) (1)
- In vitro propagation of rhubarb (Rheum rhaponticum). (1990) (1)
- HIV-1 gp41 binds to two proteins in cell culture supernatant of human B cell line Raji and monocyte cell line U937. (1994) (1)
- Cross flow diafiltration of serum with basal medium suitable for growth of hybridomas, sterilization and protein reduction. (1987) (1)
- Analysis of Genetic Parameters in Order to Get More Information on High Producing Recombinant CHO Cell Lines (2007) (1)
- The effects of oncogene transfection on growth and antibody production of human-mouse heterohybridomas (2004) (1)
- Determination of division rates of rCHO cells in high density and immobilized fermentation systems by flow cytometry (2006) (1)
- CHO-recombinant human growth hormone as a protease sensitive reporter protein (2009) (1)
- Comparison of Fluidized Bed and Fed Batch Reactor Cultures for Production of Anti-HIV-Antibody (2005) (1)
- Transformation of woody species : State of the art (2006) (1)
- Monoclonal ELISA for the determination of BNYV-virus. (1985) (1)
- Influence of Cell Culture Media on Adhesion of Animal Cells on Microcarriers (2001) (1)
- Native Antigen 4 E 10 Recognizes N-Terminal Sequences on The HIV-Neutralizing Monoclonal Antibody Tomer (2006) (1)
- Topological transformation of liposomes by a membrane-affecting domain of recombinant human erythropoietin (2009) (1)
- Molecular characterisation of Austrian Plum pox virus (PPV) isolates. (2005) (1)
- Construction of cDNA of arabis mosaic virus and its use for diagnosis. (1989) (1)
- A method and apparatus for producing lipid vesicles (2001) (1)
- Crystal Structure of the 2F5 Fab'-3H6 Fab Complex (2008) (1)
- A SIMPLE MAGNETIC DRIVEN MINI-REACTOR FOR FLUIDIZED AND PACKED BEDS (1994) (1)
- ON-LINE GLUCOSE CONTROL OF ANIMAL CELL CULTURES IN FLUIDIZED BEDS (1994) (1)
- CHARACTERISATION OF CHO SUBCLONES SHOWING PROFOUND CHANGES IN PERFORMANCE WHEN PROPAGATED IN DIFFERENT CULTIVATION SYSTEMS (2005) (1)
- HIV-1 envelope protein gp140 binding studies to human brain microvascular endothelial cells. (2007) (1)
- From Gene to Monoclonal Antibody: Efficient Screening by Cell Sorting (2005) (0)
- Development of plasmids for the preparation of nucleic acid probes specific for plum pox virus. (1990) (0)
- Carbamylated erythropoietin improves recognition memory by modulating microglia in a rat model of pain (2021) (0)
- 22. The novel protein Nopsi and its impact on the life span of Drosophila melanogaster (2009) (0)
- Deletions in the NS1 Protein Grow Efficiently in Transfectant Influenza A Viruses with Long (2013) (0)
- Characterization of an Anti-Idiotypic Antibody Blocking the Capacity of the HIV-1 Specific nMAb 2F5 (2010) (0)
- Softmix, a new Scalable Mixing System for the Cultivation of Sensitive Cells on Microcarrier under Protein- Free Conditions (2005) (0)
- Liposomal composition containing an active ingredient for smooth muscle relaxation and the therapeutic use of the composition (2005) (0)
- Virus Type 1 Isolates of Human Immunodeficiency Antibody Neutralization-Resistant Primary (1998) (0)
- In vitro propagation of Prunus armeniaca (1994) (0)
- the Native Antigen 4E10 Recognizes N-Terminal Sequences on The HIV-Neutralizing Monoclonal Antibody (2013) (0)
- Crystal structure of hiv-1 neutralizing human fab 4e10 in complex with a 16-residue peptide encompassing the 4e10 epitope on gp41 (2005) (0)
- A process for the manufacture of recombinant trypsin (2001) (0)
- CHARACTERIZATION OF HUMAN ENDOTHELIAL HYBRID CELLS EXPRESSING VON WILLEBRAND FACTOR (1992) (0)
- Production of Immunoglobulins and Monoclonal Antibodies Targeting Infectious Diseases (2002) (0)
- FAB 2G12 unliganded (2003) (0)
- liposomal composition containing an active ingredient for the relaxation of smooth muscle, making such a composition and therapeutic use. (2005) (0)
- A continuous multistage roller reactor for animal cell culture: 1. Patterns of growth, production and catabolism of a murine hybridoma (1990) (0)
- In vitro propagation of apple and aspects of setting up a gene bank. (1990) (0)
- Method and device for the preparation of lipid vesicles (2001) (0)
- Application de superoxide dismutase dans des liposomes (1995) (0)
- Against a peptide mimicking a cryptic epitope of gp41 from HIV-1 antibody directed (2002) (0)
- P04-03. Cross-clade neutralization analysis of plasmas from clade B, C and CRF01_AE HIV-infected donors (2009) (0)
- Hyperattenuated Recombinant Influenza A Virus Nonstructural-Protein-Encoding Vectors Induce Human Immunodeficiency Virus Type 1 Nef-Specific Systemic and Mucosal Immune Responses in Mice (2001) (0)
- Live Attenuated Influenza Virus Expressing Human Interleukin-2 Reveals Increased Immunogenic Potential in Young and Aged Hosts (cid:1) (2006) (0)
- ADAPTATION OF rCHO CELLS TO GROWTH IN SERUM FREE MEDIUM: A FLOW CYTOMETRIC STUDY (1992) (0)
- Human Monoclonal Antibodies Protect Neonatal and Adult Rhesus Monkeys from Mucosal or Parenteral Immunodeficiency Virus Exposure (1999) (0)
- Analysis of mitogenic activity of proteins after separation by gel electrophoresis (1999) (0)
- Anticorps monoclonaux humains anti-hiv 1 (1988) (0)
- Goldlabelled-immunosorbent electron microscopy with plum pox virus specific monoclonal antibodies. (1989) (0)
- Monoclonal antibody against human HIV-i (1988) (0)
- Interferon alpha primes early proliferative response of bone marrow cells in vivo. (1998) (0)
- Non-Invasive Adaptive Control of the Feed Rate for High Cell Density CHO Cultures According to the pO2 Profile (1999) (0)
- Correction to: CEPO (carbamylated erythropoietin)-Fc protects hippocampal cells in culture against beta amyloid-induced apoptosis: considering Akt/GSK-3β and ERK signaling pathways (2020) (0)
- Screening for monoclonal antibodies with covalently linked antigen. (1987) (0)
- Control of Key Parameters in the Development of Mammalian Production Clones (2005) (0)
- Neutralizing Antibodies Afforded by Passive Infusion of Does Not Augment the Sterile Protection Immunodeficiency Virus DNA Vaccination Immunodeficiency Virus Type 1 / Simian Cellular Immunity Elicited by Human (2003) (0)
- Application of Protein-Free Cell Culture Media for the Manufacturing of Biopharmaceuticals (2001) (0)
- Effect of carbamylated erythropoietin FC fusion protein (CEPO‐FC) on learning and memory impairment and hippocampal apoptosis induced by intracerebroventricular administration of streptozotocin in rats (2020) (0)
- Continuous Perfusion versus Discontinuous Fed-Batch (2001) (0)
- Influence of the different genetic parameters and regulatory sequences on recombinant expression on a monoclonal antibody (2008) (0)
- 865Liposomal recombinant human superoxide dismutase for the treatment of peyronie's disease: A randomized placebo-controlled double-blind clinical study (2005) (0)
- Large‐Scale Production of Lipid Microspheres (2002) (0)
- Killer T cells: a promising new tool for adoptive immunotherapy. (2002) (0)
- TS-8 CONTRACT MANUFACTURE OF CLINICAL GRADE (CHO RECOMBINANT HUMAN) MAB'S: PERFUSED FLUIDIZED BED PRODUCTION, EXPANDED BED AFFINITY PURIFICATION AND VALIDATION (2008) (0)
- Abstracts of presentations on plant protection issues at the xth international congress of virology (1997) (0)
- Liposomal composition an agent for relaxing smooth muscles containing the preparation of this composition and their therapeutic use (2005) (0)
- Protein Mass Production in Hybridomas and Recombinant CHO Cells (2001) (0)
- Transcription Profiling of Different Recombinant CHO Clones Based on Cross-species Microarray Analysis (2007) (0)
- 8. hExo70, a subunit of the exocyst complex – a possible link between vesicular transport, pre-mRNA splicing and aging? (2009) (0)
- Establishment and Characterization of Human Medullary Thyroid Carcinoma Cell Lines for Immunotherapy (2005) (0)
- Analysis of Genomic DNA and RNA-Transcripts of a Heterohybridoma SDNA imultanously Expressing IgG3 and IgG1 with Identical Specificity (1999) (0)
- Stable Recombinant Expression and Functinal Identity of the Anti HIV-I Monoclonal Antibody 2F5 after IGG3/IGGI Subclass Switch in CHO-Cells (1999) (0)
- Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 11mer epitope (2004) (0)
- Long-Term Stability Of Continuously Perfused Animal Cells Immobilized On Novel Macroporous Microcarriers (1996) (0)
- CEPO (carbamylated erythropoietin)-Fc protects hippocampal cells in culture against beta amyloid-induced apoptosis: considering Akt/GSK-3β and ERK signaling pathways (2020) (0)
- Methode de production de polypeptides dans des cultures cellulaires de mammifere (2002) (0)
- Establishment of Screening Systems for Recombinant Cell Lines: Early Prediction of the Suitability as a Production Clone (2005) (0)
- In Vivo and In Vitro Escape from Neutralizing Antibodies 2G12, 2F5, and 4E10 (cid:1) (2007) (0)
- Monoclonal antibodies to HIV-1 and manufactured thereof vaccines (1995) (0)
- Live influenza vaccine and process for its manufacture (2001) (0)
- Dismutasa superoxide application (sod) in liposomas. (1995) (0)
- A modular microsensor for monitoring fermentation processes. (1987) (0)
- Live influenza vaccine and the process for its preparation (2001) (0)
- Crystal Structure of Fab 2G12 bound to Man9GlcNAc2 (2003) (0)
- Process and device for preparing lipid vesicles. (2001) (0)
- Peptides stems neutralizing antibodies against genetically divergent HIV-1 induce (1994) (0)
- Transcriptional profiling of recombinant CHO cells by a novel inter-species analysis strategy (2006) (0)
- Cultivation of Simian Virus 40 Large T Transfected Human Endothelial Cell Lines in Serumfree Medium (1995) (0)
- Peptide having antibody inducing function to neutralize genetically divergent hiv-1 isolate (1993) (0)
- Crystal Structure of Fab 2G12 bound to Man1->2Man (2003) (0)
- Human Keratinocyte Culture on Macroporous Carries at the Air-Liquid Interface (1999) (0)
- Stopping the DNA polymerase activity at a specific site with a dideoxyoligonucleotide: selective labelling of single stranded circular DNA. (1989) (0)
- Resistance breeding against Plum pox virus (PPV) in Austria: state of the art. (2005) (0)
- 937: Liposomal Recombinant Human Superoxide Dismutase for the Treatment of Peyronie's Disease: A Randomized Placebo-Controlled Double-Blind Clinical Study (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hermann W. D. Katinger?
Hermann W. D. Katinger is affiliated with the following schools:
